Details of the Drug
General Information of Drug (ID: DMDIQ7H)
Drug Name |
3-(9-Acridinylamino)-5-(hydroxymethyl)aniline (AHMA)
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
CHEMBL321473; NSC666097; 3-(9-acridinylamino)-5-(hydroxymethyl)aniline; 154310-42-6; [3-(acridin-9-ylamino)-5-aminophenyl]methanol; AC1Q7C6S; AC1L8FG4; SCHEMBL1865418; CTK0E7866; DTXSID30327555; GZHHMAFXYHPHBO-UHFFFAOYSA-N; ZINC3799478; AKOS030584742; NCI60_022917; 3-(9-acridinylamino)-5-hydroxymethylaniline; 3-(acridin-9-yl)amino-5-hydroxymethylaniline; Benzenemethanol, 3-(9-acridinylamino)-5-amino-; [3-(acridin-9-ylamino)-5-amino-phenyl]methanol
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 315.4 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 3.5 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 3 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 3 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 4 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||